Dual Targeting of Bile Acid Receptor-1 (TGR5) and Farnesoid X Receptor (FXR) Prevents Estrogen-Dependent Bone Loss in Mice.
Li Z, Huang J, Wang F, Li W, Wu X, Zhao C, Zhao J, Wei H, Wu Z, Qian M, Sun P, He L, Jin Y, Tang J, Qiu W, Siwko S, Liu M, Luo J, Xiao J.
Li Z, et al. Among authors: wu x, wu z.
J Bone Miner Res. 2019 Apr;34(4):765-776. doi: 10.1002/jbmr.3652. Epub 2019 Jan 7.
J Bone Miner Res. 2019.
PMID: 30536462
Free article.